About NEXTCURE, INC
NextCure, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies to treat cancer patients who do not respond to current treatments, whose cancer progresses despite treatment, or who have cancer types not adequately addressed by available therapies.
Developing novel tumor-specific therapiesHarnessing an individual’s own immune system for disease treatmentFunction-based screening and translational methods to improve immune functionIdentifying positive and negative regulators of T cells, NK cells, macrophages, and myeloid-derived suppressor cellsStreamlining target validation and IND enabling studies including pharmacology, toxicology, PK/PD, ADA evaluation, tissue cross reactivity assessment, and assay developmentDeveloping products from gene cloning to final drug product with an 'All Stream' approach integrating all aspects of development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NEXTCURE, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.